Vident Advisory’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Buy
13,456
+357
+3% +$31.6K 0.01% 783
2025
Q4
$1.05M Sell
13,099
-567
-4% -$47.5K 0.01% 784
2025
Q3
$1.33M Sell
13,666
-3,080
-18% -$248K 0.01% 709
2025
Q2
$1.17M Sell
16,746
-2,211
-12% -$126K 0.01% 682
2025
Q1
$942K Sell
18,957
-16,453
-46% -$1.04M 0.01% 748
2024
Q4
$2.47M Buy
35,410
+12,060
+52% +$1M 0.04% 363
2024
Q3
$2.45M Buy
23,350
+19,874
+572% +$2.32M 0.06% 339
2024
Q2
$494K Buy
+3,476
New +$401K 0.01% 882
2024
Q1
Sell
-3,426
Closed -$444K 1325
2023
Q4
$444K Sell
3,426
-423
-11% -$58.3K 0.01% 833
2023
Q3
$628K Buy
+3,849
New +$677K 0.02% 637

Other funds holding ACLS

Vident Advisory's ACLS Position: Q1 2026 in Review

Vident Advisory increased its Axcelis (ACLS) stake by 2.7% in Q1 2026, buying an estimated $31.6K and bringing the position to 13,456 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #783.

Vident Advisory first reported a position in ACLS in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.47M in Q4 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Vident Advisory held 13,456 shares of Axcelis worth $1.25M as of Q1 2026.
  • Vident Advisory bought 357 Axcelis shares in Q1 2026, an estimated $31.6K.
  • Axcelis made up 0.01% of Vident Advisory's portfolio in Q1 2026, its #783 holding.
  • Vident Advisory first reported a position in Axcelis in Q3 2023 and has held it in 10 quarters since.
  • Vident Advisory's Axcelis position peaked at $2.47M in Q4 2024.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.